Skip to main content
Signal8

MacLean Alexandra

SEC insider (Form 3/4/5 filer). CIK 0001940880. Chief Executive Officer at AVENUE THERAPEUTICS, INC. (ATXI). 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 23, 2024. Located in BAY HARBOR ISLANDS, FL.

Companies MacLean Alexandra has filed insider reports for

  • AVENUE THERAPEUTICS, INC. (ATXI): Director, Officer, Chief Executive Officer
MacLean Alexandra profile photo

MacLean Alexandra

CIK: 0001940880

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AVENUE THERAPEUTICS, INC. logo
ATXI

AVENUE THERAPEUTICS, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • AVENUE THERAPEUTICS, INC. logo
    ATXI

    AVENUE THERAPEUTICS, INC.

    Sep 23, 2024
    Award
    Direct
    170K shares-

1-1 of 1